Director, Interventional Fellowship Program

E-Mail

Hospital of The University of Pennsylvania
Department of Medicine
Cardiovascular Medicine Division
9.119 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283

Appointments
Contact: Kathy Cristinziani (215) 662-2181

Clinical Specialty:

• Cardiovascular Medicine

Practice Location:

• Hospital of The University of Pennsylvania, Founders Pavilion

Education:

• MD: Cornell University Medical College, NY, NY
• Residency: Yale-New Haven Hospital, New Haven, CT
• Fellowship: Cardiovascular Laboratory, Duke University Medical Center, Durham, NC
• Postdoctoral Fellowship: Cornell University Medical College, NY, NY

Research Interest:

• <not available>

Selected Publications:

1. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr., Herrmann HC, and Laskey WK: Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82:2044-2051, 1990.
2. Macdonald RG, Henderson MA, Hirshfeld JW Jr, Goldberg SH, Bass T, Vetrovec G, Cowley M, Taussig A, Whitworth H, Margolis JR, et al.: Patient-Related Variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-Heart Group. Am J Cardiology 66:926-31, 1990.
3. Hirshfeld JW Jr, Ventricular Fibrillation durind coronary arteriography [letter] Cath and Cardiov Diag 20:287, 1990.
4. Hill JA, Macdonald RG, Jugo R, Hirshfeld JW Jr, Goldberg S, Savage MP, Vetrovec G, Cowley M, Bass TA, Margolis JR, et al.: Multi-Hospital Eastern Atlantic Restenosis Trial: Design, recruitment, and feasibility. M Heart Investigators, Cath and Cardiov Diag 20:227-237, 1990.
5. Schatz RA, Goldberg S, Leon M, Baim D, Hirshfeld JW Jr, Cleman M, Ellis S, Topol E: Clinical experience with the Palmaz-Schatz Coronary Stent. J Am Coll Cardiology 17:155B-159B, 1991.
6. Savage MP, Goldberg S, Hirshfeld JW Jr, Bass TA, Macdonald RG, Margolis JR, Taussig AS, Vetrovec G, Whitworth HB, Zalewski A, et al: Clinical and angiographic determinants of primary coronary angioplasty success. M Heart Investigators. J Am Coll Cardiology 17:22-28,1991.
7. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW Jr, Cleman MW, Cabin HS, Walker C, Stagg J, Buchbinder M, Teirstein PS, Topol EJ, Savage M, Perez JA, Curry RC, Whitworth H, Sousa E, Tio F, Almagor Y, Ponder R, Penn IM, Leonard B, Levine SL, Fish RD, and Palmaz JC: Clinical Experience with the Palmaz-Schatz Coronary Stent. Initial Results of a Multicenter Study. Circulation 83:148-161, 1991.
8. Hirshfeld JW Jr., Schwartz JS, Jugo R, Macdonald RG, Goldberg S, Savage M, Bass TA, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Pepine CJ, M-Heart Investigators: Restenosis after Coronary Angioplasty. A Multivariate Statistical Model to Relate Lesion and Procedure Variables to Restenosis. J Am Coll Cardiol 18:647-56, 1991.
9. Matthai WH Jr, Hirshfeld JW Jr: Choice of Contrast Agents for Cardiac Angiography--Review and recommendations based on Clinically important distinctions. Cath and Cardio Diag 22:278-289, 1991.
10. Herrmann HC, Buchbinder M, Cleman MW, Fischman D, Goldberg S, Leon MB, Schatz RA, Tierstein P, Walker CM, Hirshfeld JW,. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992; 86:812-19.